Fermion Oy

Fermion Oy is a fully integrated CDMO and API manufacturer, leveraging its position within the Orion Group to offer end-to-end services from development to commercial manufacturing. The company has a dual focus on generic APIs and exclusive contract manufacturing for new chemical entities (NCEs), with specialized capabilities in highly potent compounds and semi-solid/liquid drug products. With recent investments to expand API capacity and a strong regulatory track record including FDA inspections, Fermion is positioned as a strategic European partner for pharmaceutical outsourcing.

Integrated API and drug product CDMO services with core competencies in chemical process development, crystallization, and Highly Potent API (HPAPI) manufacturing. Drug product focus on semi-solids, liquids, cytotoxic oral solids, and packaging.

Fermion competes in the global CDMO market against large players like Lonza, Catalent, and Siegfried, as well as specialized API manufacturers. Its key differentiators are its full integration with Orion's drug product capabilities, strong HPAPI focus, and reputation for high-quality, EU-based manufacturing. Competition is intense on cost, especially in generics, and on technological breadth.